RARA CRAFT DATABASE for FDA Medical Devices
510(k)K150832

FDA DEVICE FACTS

U2 Femoral Component, CR, Porous Coated, Additional Sizes

United Orthopedic Corporation

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATESeptember 25, 2015PRODUCT CODEMBH

Indications for use

The U2 Total Knee system is indicated in knee arthroplasty for reduction or relief of pain and/or improved knee function in skeletally ma ture patients with seve re knee pain and disability due to rheumatoid arthritis, osteoarthr itis, primary and secondary traumatic arthritis, polyarthritis, collagen disorders, avas cular necrosis of the femoral condyle or pseudogout, posttraumatic loss of joint c onfiguration, particularly when there is patellofemoral erosion, dysfunction or prior patellectomy, moder ate valgus, varus, or flexion deformities. This device may also be indicated in the sa lvage of previously failed surgical attempts if the knee can be satisfa ctorily balanced and stabilized at the time of surgery. This device is a single use implant and intended for cementless use only.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 5, 2026